Carol J. Schramke

984 total citations
28 papers, 696 citations indexed

About

Carol J. Schramke is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Carol J. Schramke has authored 28 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Psychiatry and Mental health. Recurrent topics in Carol J. Schramke's work include Multiple Sclerosis Research Studies (8 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Carol J. Schramke is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Carol J. Schramke collaborates with scholars based in United States. Carol J. Schramke's co-authors include Thomas F. Scott, James Valeriano, Kevin M. Kelly, Howard N. Garb, Cynthia A. Munro, Russell M. Bauer, Kevin W. Greve, Meryl A. Butters, Judith Saxton and Melissa McNeil and has published in prestigious journals such as Psychological Bulletin, Neurology and Journal of Consulting and Clinical Psychology.

In The Last Decade

Carol J. Schramke

28 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol J. Schramke United States 15 208 171 139 132 94 28 696
Ayşe Sağduyu Kocaman Türkiye 13 165 0.8× 131 0.8× 124 0.9× 265 2.0× 99 1.1× 39 831
Martin Rakuša Slovenia 13 214 1.0× 62 0.4× 95 0.7× 76 0.6× 29 0.3× 44 609
Yen‐Ho Wang Taiwan 16 213 1.0× 321 1.9× 78 0.6× 96 0.7× 59 0.6× 35 880
Sonia Santos Lasaosa Spain 15 438 2.1× 238 1.4× 117 0.8× 236 1.8× 33 0.4× 124 765
Ralph Benedict United States 12 234 1.1× 174 1.0× 64 0.5× 168 1.3× 52 0.6× 33 742
Joseph Kaleyias United States 17 407 2.0× 147 0.9× 159 1.1× 37 0.3× 108 1.1× 30 974
Kadriye Armutlu Türkiye 12 270 1.3× 344 2.0× 56 0.4× 209 1.6× 54 0.6× 36 799
S. Gunawardene United States 8 561 2.7× 210 1.2× 43 0.3× 72 0.5× 52 0.6× 8 1.4k
Peter A. Blasco United States 17 246 1.2× 48 0.3× 71 0.5× 291 2.2× 92 1.0× 29 988
Alvin Y. Chan United States 17 208 1.0× 199 1.2× 44 0.3× 309 2.3× 28 0.3× 50 823

Countries citing papers authored by Carol J. Schramke

Since Specialization
Citations

This map shows the geographic impact of Carol J. Schramke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol J. Schramke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol J. Schramke more than expected).

Fields of papers citing papers by Carol J. Schramke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol J. Schramke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol J. Schramke. The network helps show where Carol J. Schramke may publish in the future.

Co-authorship network of co-authors of Carol J. Schramke

This figure shows the co-authorship network connecting the top 25 collaborators of Carol J. Schramke. A scholar is included among the top collaborators of Carol J. Schramke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol J. Schramke. Carol J. Schramke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scott, Thomas F., et al.. (2021). Self‐Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease. Movement Disorders Clinical Practice. 8(4). 631–633. 10 indexed citations
2.
Scott, Thomas F., et al.. (2019). Multiple sclerosis relapses contribute to long‐term disability. Acta Neurologica Scandinavica. 140(5). 336–341. 10 indexed citations
3.
Scott, Thomas F., et al.. (2018). Impacting The Natural History of Multiple Sclerosis: A Report on the First Generation of Treated Patients (P5.030). Neurology. 90(15_supplement). 1 indexed citations
4.
Schramke, Carol J., et al.. (2016). Medication Reduction After DBS Placement in Parkinson’s Disease (P6.383). Neurology. 86(16_supplement). 1 indexed citations
5.
Scott, Thomas F., et al.. (2014). Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model. Clinical Neurology and Neurosurgery. 127. 86–92. 11 indexed citations
6.
Scott, Thomas F., et al.. (2013). Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients. Journal of the Neurological Sciences. 330(1-2). 27–31. 11 indexed citations
7.
Valeriano, James, et al.. (2013). Ketamine use in the treatment of refractory status epilepticus. Epilepsy Research. 105(1-2). 183–188. 91 indexed citations
8.
Hackett, Claire, et al.. (2012). Vitamin D Levels Predict Severity of MS and Relapse Activity (P05.103). Neurology. 78(Meeting Abstracts 1). P05.103–P05.103. 1 indexed citations
9.
Valeriano, James, et al.. (2011). The efficacy of topiramate in adult refractory status epilepticus: Experience of a Tertiary Care Center. Epilepsy Research. 98(2-3). 232–237. 25 indexed citations
10.
Scott, Thomas F., et al.. (2010). Neurosarcoidosis Mimicry of Multiple Sclerosis. The Neurologist. 16(6). 386–389. 28 indexed citations
11.
Schramke, Carol J., et al.. (2010). Using patient history to distinguish between patients with non-epileptic and patients with epileptic events. Epilepsy & Behavior. 19(3). 478–482. 14 indexed citations
12.
Scott, Thomas F. & Carol J. Schramke. (2010). Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later. Journal of the Neurological Sciences. 292(1-2). 52–56. 42 indexed citations
13.
Schramke, Carol J., et al.. (2007). Using the Minnesota Multiphasic Inventory 2, EEGs, and clinical data to predict nonepileptic events. Epilepsy & Behavior. 11(3). 343–346. 16 indexed citations
14.
Scott, Thomas F., et al.. (2007). Aggressive Therapy for Neurosarcoidosis. Archives of Neurology. 64(5). 691–691. 102 indexed citations
15.
Saxton, Judith, Cynthia A. Munro, Meryl A. Butters, Carol J. Schramke, & Melissa McNeil. (2000). Alcohol, Dementia, and Alzheimer's Disease: Comparison of Neuropsychological Profiles. Journal of Geriatric Psychiatry and Neurology. 13(3). 141–149. 49 indexed citations
16.
Goldstein, Gérald, Ruth Condray, Carol J. Schramke, Robert Stowe, & Graham Ratcliff. (1998). Poststroke Depression and Anxiety: Different Assessment Methods Result in Variations in Incidence and Severity Estimates. Journal of Clinical and Experimental Neuropsychology. 20(5). 723–737. 46 indexed citations
17.
Schramke, Carol J., et al.. (1997). State-dependent learning in older and younger adults.. Psychology and Aging. 12(2). 255–262. 25 indexed citations
18.
Garb, Howard N. & Carol J. Schramke. (1996). Judgment research and neuropsychological assessment: A narrative review and meta-analyses.. Psychological Bulletin. 120(1). 140–153. 41 indexed citations
19.
Bauer, Russell M., Kevin W. Greve, E. L. Besch, Carol J. Schramke, & et al.. (1992). The role of psychological factors in the report of building-related symptoms in sick building syndrome.. Journal of Consulting and Clinical Psychology. 60(2). 213–219. 4 indexed citations
20.
Greve, Kevin W., Russell M. Bauer, M R Ware, et al.. (1991). Sick Building Syndrome. Southern Medical Journal. 84(1). 65–71. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Sağduyu Kocaman Breakdown of academic impact, for papers by Martin Rakuša Breakdown of academic impact, for papers by Yen‐Ho Wang Breakdown of academic impact, for papers by Sonia Santos Lasaosa Breakdown of academic impact, for papers by Ralph Benedict Breakdown of academic impact, for papers by Joseph Kaleyias Breakdown of academic impact, for papers by Kadriye Armutlu Breakdown of academic impact, for papers by S. Gunawardene Breakdown of academic impact, for papers by Peter A. Blasco Breakdown of academic impact, for papers by Alvin Y. Chan
Rankless by CCL
2026